Company intelligence / Profile preview

AngioScan Biotech

Moscow, Moscow, Russia

Ownership: Private
Development stage: Other

Overview

AngioScan is a medical technology company specializing in the development and manufacturing of non-invasive diagnostic devices for cardiovascular health assessment. The company's primary technology utilizes pulse wave analysis to evaluate arterial stiffness, endothelial function, and the biological age of the vascular system. Their product line includes professional clinical systems and portable devices designed for both healthcare providers and personal health monitoring. By providing early detection of vascular abnormalities, AngioScan aims to facilitate the prevention and management of cardiovascular diseases such as atherosclerosis and hypertension.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: DeviceDiagnostic
Industry: Physiological Monitoring

Beyond the preview

Go deeper on AngioScan Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AngioScan Biotech.

Explore the full profile